Correlation Between Cannara Biotech and Nunzia Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Nunzia Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Nunzia Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Nunzia Pharmaceutical, you can compare the effects of market volatilities on Cannara Biotech and Nunzia Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Nunzia Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Nunzia Pharmaceutical.

Diversification Opportunities for Cannara Biotech and Nunzia Pharmaceutical

0.0

Correlation Coefficient

Cannara Biotech  Nunzia Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Cannara and Nunzia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Nunzia Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nunzia Pharmaceutical and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Nunzia Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nunzia Pharmaceutical has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Nunzia Pharmaceutical go up and down completely randomly.

Pair Corralation between Cannara Biotech and Nunzia Pharmaceutical

If you would invest  59.00  in Cannara Biotech on December 1, 2024 and sell it today you would earn a total of  36.00  from holding Cannara Biotech or generate 61.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  Nunzia Pharmaceutical

Cannara Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Nunzia Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nunzia Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Nunzia Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cannara Biotech and Nunzia Pharmaceutical

The main advantage of trading using opposite Cannara Biotech and Nunzia Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Nunzia Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nunzia Pharmaceutical will offset losses from the drop in Nunzia Pharmaceutical's long position.

The idea behind Cannara Biotech and Nunzia Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.